tirzepatide pipeline 🧬 New research presented at the Endocrine Society's 2025 meeting reveals that GLP-1 medications—like semaglutide (Ozempic), dulaglutide (Trulicity), and (Mounjaro)—may do more than support weight loss and blood sugar control. These OBESITY PIPELINE LOOKS PROMISING :

The FDA and DOJ now treat it as an illegal drug and for good reason, given the unknown safety profile

Persistent nocturia may have causes unrelated to tirzepatide that need investigation, including prostate enlargement in men, overactive bladder, or sleep apnea

These quick-reference tables organize the data by dose level so you can find your specific number in seconds

Diabetic retinopathy complications may occur in patients with pre-existing diabetic eye disease, particularly with rapid improvement in glycemic control

You may, however, experience subtle changes in the foods you crave, or you might feel fuller sooner than usual